Member Info for Lostapound

HFH - Made transfer trial runs were undertaken in December....

Around November last year, I suggested that the Made transfer time be finished and announced in March-April. I got absolutely pilloried. You were one them MrI. So you need to wind your neck in. If you dish it out, except to reap what you sow.

Now we are in March, and people are saying they expect an announcement. Strange, really.

JHFH said I was randomly adding on extra months. Hemo didn't need money in Feb. Just 2 examples of JHFH being wrong. So, dear viewer, new or old, I don't believe either JHFH or HFH have ever said anything that has been correct or True.

There's always tomorrow.

Looks like the 500 block buys being sold for nice profit.

Even on the friendly home ground of Share Dive, they think you're a gimp 🤣.

I've got my shares, had them years now. All at a lower average than you. Cheers 🍻

The Trump ego war has nothing to with the price, which has remained stable.

Err... No one is currently trying to prise them from our hands.

I think Estonia will only progress after the Made transfer is completed and there is evidence of safety from the Made produced CAR-T and this is confirmed.

My estimate for completion was early March, possibly a more broader March-April period. My only concern is Vlad's final stages timeline.

Nothing today. Just a jab at those who keep saying the Hemo rocket is taking off.

And I will be around until my sale price is met, spouting facts from RNSs and any prospectus that gets released.

Bless you and all who are aboard the good ship Hemo.

Someone needs to check the Hemo engines. They've spluttered and stalled again.

If only the trial had continued during the transfer. All that lovely data to add value.

There were big buys going through when the price went up for no reason. I'm expecting these people have given up waiting and are taking their reduced profits.

Until the self-imposed trial hold is ended when the Made transfer is complete, and the next patients are injected and safe, or news on P1, P2, or P3 is released, we're in limbo.

I currently think far too much emphasis is being put on the Letter of Intent.

It's now a question of how long Vlad's 'final stages' of transfer take to complete. But I think it shows that trial runs didn't take place in December or January.

Now this is something I thought in relation to presenting at conferences, but I was told on here this is not necessarily the case.

P1 has passed the 12-month point since injection and P3 has passed the 6-month point since injection. Will we get any form of update on all 3 patients?

I was hoping for something in the last week of February, but I was wrong.

The simple fact is that we only know what is mentioned in the RNSs. Anything else is pure conjecture, and that's being generous.

Short answer is yes, yes it does matter.

As I said a few weeks ago, after about 2 weeks, any death is unlikely to be a result of treatment, and the further beyond this time it goes, the less likely it is to be treatment-related. Any death would bring into question the durability, particularly at the lower dose.

The Made transfer we all know is happening. How much of this is already factored into the price will be interesting to see. Big price movers will be the announcement that P4 and/or Child 1 has been injected and that this has been well tolerated without the need for intervention.